
The bispecific era in multiple myeloma — Future directions: Written recap
C. Brooke Adams, Pharm.D., BCOP, of Orlando Health discusses bispecific antibody therapies for multiple myeloma.

C. Brooke Adams, Pharm.D., BCOP, of Orlando Health discusses bispecific antibody therapies for multiple myeloma.

Mike Badome is chief actuary of Arcadia, an outcomes company that helps healthcare organizations improve cost, quality and operational performance.

Bahar Davidoff, Pharm.D., MBA, is founder and principal of Davidoff Strategy and Consulting, a healthcare advisory firm focused on healthcare operations, pharmacy strategy and artificial intelligence (AI) integration.

Sham Firdausi, M.P.H., M.Sc., MBA, is deputy chief financial officer of the Santa Clara Valley Healthcare, one of the largest public health systems in the country and California’s second-largest county-owned health and hospital system.

Manjula D. Jayabalan, Pharm.D., MBA, is senior director of pharmacy at WTW, a multinational advisory and brokerage firm.

Zach Jones, Pharm.D., is senior director of clinical formulary strategy, Prime Therapeutics, a Minnesota-based pharmacy benefit manager.

How Banjo Health uses generative AI to speed prior authorizations, cut paperwork, and scale fair, transparent utilization management across plans.

HaVy Ngo-Hamilton, Pharm.D., senior pharmacy director, Buzz Health, a healthcare technology company offering prescription savings solutions that integrate with health systems to promote price transparency and cost-effectiveness.

Mike Nguyen is senior director of external affairs at AlohaCare, a community-led nonprofit health plan in Honolulu, Hawaii.

Brianna Oddi, Pharm.D. Brianna Oddi, Pharm.D., is senior clinical account manager of PANTHERx Rare Pharmacy

Carly Rodriguez, Pharm.D., is vice president and chief pharmacy officer, Moda Health and immediate past president of the Academy of Managed Care Pharmacy

Alyana Samai, M.P.H., is corporate vice president, neuroscience and musculoskeletal services, at LCMC Health, an eight-hospital, New Orleans-based nonprofit health system.

Lorece Shaw, Pharm.D., is director of clinical account consulting at Capital Rx, a pharmacy benefit and management company.

The use of unsanctioned or unapproved artificial intelligence by healthcare workers created a significant liability risk, experts say.